Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Featured here are the animal health mergers and acquisitions covered by Animal Pharm during 2017.
Dechra Pharmaceuticals has again returned to Australasia for its latest acquisition.
French animal feed additives specialist Adisseo has acquired Belgian firm Nutriad for an undisclosed amount.
Leading US veterinary products distributor MWI Animal Health has strengthened its position on the country's eastern seaboard with the purchase of the Northeast Veterinary Supply Company (NEVSCO).
Merck Animal Health has acquired Uruguayan veterinary vaccine specialist Prondil.
This year, Dechra Pharmaceuticals celebrated its 20th birthday. The previous two decades have seen the firm stimulate its turnover – and share price – with a combination of acquisitions and organic growth. Animal Pharm editor Joseph Harvey takes a look at what the coming years hold for the leading UK-based animal health company.
Earlier this month, a joint webinar from Animal Pharm and Kisaco Research canvassed the opinions of three key industry experts regarding the state of innovation in animal health. Animal Pharm editor Joseph Harvey spoke to Nesya Goris of ViroVet, Theo Kanellos from Zoetis and George Gunn from Stonehaven Consulting. Below is a transcript of the webinar.
Virbac has put its pending acquisition of Chilean fish vaccine business Centrovet on ice for the next three years.
Vetoquinol has acquired a small stake in Plant Advanced Technologies (PAT), a fellow French firm focused on developing plant-based biotechnology.
MSD Animal Health is to significantly increase its presence in Turkey by acquiring the country's leading manufacturer of veterinary medicines.
Cargill has sold its Switzerland-based animal feed business to German investment company Aurelius Equity Opportunities for an undisclosed fee.
Zoetis has purchased the remaining 55% ownership stake in its Jilin Zoetis Guoyuan joint venture.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.